Both IFN-α and IFN-γ were found to increase LGALS3BP mRNA expression and secretion in ovarian carcinoma cell lines, whereas other treatments, such as IL-1β and TNF-α, did not consistently affect LGALS3BP secretion [48]. The gene discussed is LGALS3BP; the disease is ovarian carcinoma.